Lead Author to Revise COI Statement in Article Used to Promote Antidepressant Cymbalta

March 19, 2014
The first author of an article used by Shionogi and Eli Lilly Japan to promote the antidepressant Cymbalta (duloxetine) told Jiho that he is revising its statement on conflicts of interest (COI). The article presented the results of a survey...read more